Mild cognitive impairment and mild dementia: A clinical perspective

Mayo Clinic Proceedings

Volumn 89, Issue 10, 2014, Pages 1452-1459

  Knopman, David S ^a   Petersen, Ronald C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; RIVASTIGMINE;

ALZHEIMER DISEASE; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); COGNITION; DEMENTIA; DEPTH PERCEPTION; DIAGNOSTIC APPROACH ROUTE; DISEASE ASSOCIATION; DISEASE SEVERITY; DSM-5; EXECUTIVE FUNCTION; GENERAL PRACTITIONER; HUMAN; INTERNIST; LANGUAGE PROCESSING; LEARNING; MEDICAL EDUCATION; MEDICAL RESEARCH; MEMORY; MILD COGNITIVE IMPAIRMENT; PATIENT CARE; PROFESSIONAL KNOWLEDGE; PROGNOSIS; PSYCHOMOTOR PERFORMANCE; REVIEW; TREATMENT DURATION; TREATMENT RESPONSE; AGED; CASE REPORT; COMPLICATION; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; MALE; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY;

AGED; COGNITION; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84908093671     PISSN: 00256196     EISSN: 19425546     Source Type: Journal    
DOI: 10.1016/j.mayocp.2014.06.019     Document Type: Review

References (42)

1. B.L. Plassman, K.M. Langa, and G.G. Fisher Prevalence of dementia in the United States: the Aging, Demographics, and Memory Study Neuroepidemiology 29 1-2 2007 125 132
2. R.C. Petersen, R.O. Roberts, and D.S. Knopman Prevalence of mild cognitive impairment is higher in men: the Mayo Clinic Study of Aging Neurology 75 10 2010 889 897
3. D.S. Knopman, R.C. Petersen, W.A. Rocca, E.B. Larson, and M. Ganguli Passive case-finding for Alzheimer's disease and dementia in two U.S. communities Alzheimers Dement 7 1 2011 53 60
4. R.C. Petersen Mild cognitive impairment as a diagnostic entity J Intern Med 256 3 2004 183 194
5. M.S. Albert, S.T. DeKosky, and D. Dickson The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 3 2011 270 279
6. G.M. McKhann, D.S. Knopman, and H. Chertkow The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 3 2011 263 269
7. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders: DSM-5 5th ed. 2013 American Psychiatric Association Washington, DC
8. R.C. Petersen Clinical practice: mild cognitive impairment N Engl J Med 364 23 2011 2227 2234
9. R.O. Roberts, D.S. Knopman, and M.M. Mielke Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal Neurology 82 4 2014 317 325
10. T.D. Koepsell, and S.E. Monsell Reversion from mild cognitive impairment to normal or near-normal cognition: risk factors and prognosis Neurology 79 15 2012 1591 1598
11. O.L. Lopez, J.T. Becker, and Y.F. Chang Incidence of mild cognitive impairment in the Pittsburgh Cardiovascular Health Study-Cognition Study Neurology 79 15 2012 1599 1606
12. D. Galasko, S.D. Edland, J.C. Morris, C. Clark, R. Mohs, and E. Koss The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part XI: clinical milestones in patients with Alzheimer's disease followed over 3 years Neurology 45 8 1995 1451 1455
13. R.C. Petersen, P.S. Aisen, and L.A. Beckett Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization Neurology 74 3 2010 201 209
14. R.E. Amariglio, M.K. Townsend, F. Grodstein, R.A. Sperling, and D.M. Rentz Specific subjective memory complaints in older persons may indicate poor cognitive function J Am Geriatr Soc 59 9 2011 1612 1617
15. J.J. Manly, M.X. Tang, N. Schupf, Y. Stern, J.P. Vonsattel, and R. Mayeux Frequency and course of mild cognitive impairment in a multiethnic community Ann Neurol 63 4 2008 494 506
16. F. Jessen, B. Wiese, C. Bachmann German Study on Aging, Cognition and Dementia in Primary Care Patients Study Group Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment Arch Gen Psychiatry 67 4 2010 414 422
17. R.I. Pfeffer, T.T. Kurosaki, C.H. Harrah Jr., J.M. Chance, and S. Filos Measurement of functional activities in older adults in the community J Gerontol 37 3 1982 323 329
18. E. Teng, B.W. Becker, E. Woo, D.S. Knopman, J.L. Cummings, and P.H. Lu Utility of the Functional Activities Questionnaire for distinguishing mild cognitive impairment from very mild Alzheimer disease Alzheimer Dis Assoc Disord 24 4 2010 348 353
19. United States Agency for Health Care Policy and Research Early Identification of Alzheimer's Disease and Related Dementias 1996 US Dept of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research Rockville, MD Clinical Practice Guideline 19
20. Z.S. Nasreddine, N.A. Phillips, and V. Bédirian The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment J Am Geriatr Soc 53 4 2005 695 699
21. H.C. Rossetti, L.H. Lacritz, C.M. Cullum, and M.F. Weiner Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample Neurology 77 13 2011 1272 1275
22. D.F. Tang-Wai, D.S. Knopman, and Y.E. Geda Comparison of the Short Test of Mental Status and the Mini-Mental State Examination in mild cognitive impairment Arch Neurol 60 12 2003 1777 1781
23. E. Kokmen, G.E. Smith, R.C. Petersen, E. Tangalos, and R.C. Ivnik The Short Test of Mental Status: correlations with standardized psychometric testing Arch Neurol 48 7 1991 725 728
24. J.A. Fields, T.J. Ferman, B.F. Boeve, and G.E. Smith Neuropsychological assessment of patients with dementing illness Nat Rev Neurol 7 12 2011 677 687
25. D.S. Knopman, S.T. DeKosky, and J.L. Cummings Practice parameter: diagnosis of dementia (an evidence-based review); report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 56 9 2001 1143 1153
26. R.C. Petersen, J.C. Stevens, and M. Ganguli Practice parameter: early detection of dementia; mild cognitive impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 56 9 2001 1133 1142
27. G.A. Jicha, J.E. Parisi, and D.W. Dickson Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia Arch Neurol 63 5 2006 674 681
28. J.A. Schneider, Z. Arvanitakis, S.E. Leurgans, and D.A. Bennett The neuropathology of probable Alzheimer disease and mild cognitive impairment Ann Neurol 66 2 2009 200 208
29. J.A. Schneider, Z. Arvanitakis, W. Bang, and D.A. Bennett Mixed brain pathologies account for most dementia cases in community-dwelling older persons Neurology 69 24 2007 2197 2204
30. J. Molano, B. Boeve, and T. Ferman Mild cognitive impairment associated with limbic and neocortical Lewy body disease: a clinicopathological study Brain 133 pt 2 2010 540 556
31. N.T. Lautenschlager, K.L. Cox, and L. Flicker Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial [published correction appears in JAMA. 2009;301(3):276] JAMA 300 9 2008 1027 1037
32. M.L. Daviglus, B.L. Plassman, and A. Pirzada Risk factors and preventive interventions for Alzheimer disease: state of the science Arch Neurol 68 9 2011 1185 1190
33. R.C. Petersen, R.G. Thomas, and M. Grundman Alzheimer's Disease Cooperative Study Group. Vitamin E and donepezil for the treatment of mild cognitive impairment N Engl J Med 352 23 2005 2379 2388
34. R.S. Doody, S.H. Ferris, and S. Salloway Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial Neurology 72 18 2009 1555 1561
35. M. Bond, G. Rogers, and J. Peters The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model Health Technol Assess 16 21 2012 1 470
36. P. Raina, P. Santaguida, and A. Ismaila Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline Ann Intern Med 148 5 2008 379 397
37. R.C. Petersen, B. Caracciolo, C. Brayne, S. Gauthier, V. Jelic, and L. Fratiglioni Mild cognitive impairment: a concept in evolution J Intern Med 275 3 2014 214 228
38. J.S. Lin, E. O'Connor, R.C. Rossom, L.A. Perdue, and E. Eckstrom Screening for cognitive impairment in older adults: a systematic review for the U.S. Preventive Services Task Force [published correction appears in Ann Intern Med. 2014;160(1):72] Ann Intern Med 159 9 2013 601 612
39. C.M. Clark, J.A. Schneider, B.J. Bedell AV45-A07 Study Group Use of florbetapir-PET for imaging β-amyloid pathology JAMA 305 3 2011 275 283
40. D.T. Chien, S. Bahri, and A.K. Szardenings Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807 J Alzheimers Dis 34 2 2013 457 468
41. R.C. Petersen, P. Aisen, and B.F. Boeve Mild cognitive impairment due to Alzheimer disease in the community Ann Neurol 74 2 2013 199 208
42. V.J. Lowe, P.J. Peller, and S.D. Weigand Application of the National Institute on Aging-Alzheimer's Association AD criteria to ADNI Neurology 80 23 2013 2130 2137